Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Mouth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01484769
What this trial is testing

Method Development and Assessment of the Effects of Tobacco Products on Oral Cavity Cells

Who this might be right for
Squamous Cell Carcinoma
University of Louisville
Not applicableStudy completedNCT01318005
What this trial is testing

Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation

Who this might be right for
Oral Contraceptive
University of Southern California 82
Not applicableLooking for participantsNCT07664683
What this trial is testing

Impact of Changing the Appearance of Oral Antineoplastics on Adherence and Continuity of Treatment, Patient-reported Health Outcomes, and Patient Experience of Care

Who this might be right for
Adherence, PatientCancer
Universidad Miguel Hernandez de Elche 334
Early research (Phase 1)Ended earlyNCT04804254
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers

Who this might be right for
B-cell Lymphoma
AbbVie 5
Not applicableActive Not RecruitingNCT05934929
What this trial is testing

Contribution of Residual Tumour DNA Testing on the Surgical Bed

Who this might be right for
Squamous Cell Carcinoma of the Oral Cavity
Centre Henri Becquerel 31
Not applicableLooking for participantsNCT04452162
What this trial is testing

Physiologic MR Imaging of Salivary Gland Tumors

Who this might be right for
Salivary Gland Tumor
Abramson Cancer Center at Penn Medicine 30
Testing effectiveness (Phase 2)Study completedNCT01449461
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of the Oral Anaplastic Lymphoma Kinase (ALK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Brigatinib (AP26113)

Who this might be right for
Lymphoma, Large-Cell, AnaplasticCarcinoma, Non-Small-Cell Lung
Ariad Pharmaceuticals 137
Testing effectiveness (Phase 2)UnknownNCT05823623
What this trial is testing

Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Testing effectiveness (Phase 2)Ended earlyNCT00646659
What this trial is testing

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 47
Early research (Phase 1)Ended earlyNCT01975688
What this trial is testing

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

Who this might be right for
Head and Neck Squamous Cell Carcinoma
GW Pharmaceuticals Ltd 10
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Not applicableStudy completedNCT01338389
What this trial is testing

Influence of Oral Treatment With Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treated for Uveal Melanomas With Proton Beam Therapy

Who this might be right for
Uveal Melanoma
Centre Hospitalier Universitaire de Nice 21
Not applicableEnded earlyNCT00898742
What this trial is testing

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 58
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT05727761
What this trial is testing

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

Who this might be right for
Oral Leukoplakia
University of Minnesota 36
Testing effectiveness (Phase 2)Study completedNCT03377179
What this trial is testing

ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaCholangiocarcinoma Non-resectableCholangiocarcinoma, Perihilar+2 more
RedHill Biopharma Limited 65
Testing effectiveness (Phase 2)Study completedNCT01091103
What this trial is testing

Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide

Who this might be right for
Metastatic Progressive Castration-resistant Prostate Cancer
Pfizer 60
Not applicableLooking for participantsNCT04534127
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 56
Not applicableUnknownNCT05024383
What this trial is testing

Dissecting the Heterogeneity of Oral Cancer Pain

Who this might be right for
Oral Squamous Cell Carcinoma
NYU College of Dentistry 80
Early research (Phase 1)Study completedNCT01929603
What this trial is testing

Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumours
AstraZeneca 32
Next Page